Stem Cells Live: Current and Future Trends in Regenerative Medicine

Challenging opening comments by Greg Bonfiglio to initiate this discussion session with a bang. A series of complications have hit the industry in recent days: failure of the Athersys phase two trial, federal reimbursement for wound healing Apligraf (Organogenesis) cut. The question posed is, ‘where is the industry now and are these events predicative of the future?’ Alain Vertes, Managing …

Stem Cells Live: An Investor’s Guide to Stem Cells

‘People have no idea how well the industry is doing right now’ These were the words of Conkos Securities’ Navid Malik during his presentation this morning. And he wasn’t alone in singing the praises of the industry and it’s financial performance over the last few years. Both Greg Bonfiglio, MD Proteus Venutre Partners, and Dr Michael West, CEO BioTime, also …